Effect of lipid on the access of ATP and calcium to the delipidated Ca++-ATPase of intestinal brush border membrane

Kinetics of the immune responses during the course of hepatic amoebic infection--an experimental study

Following intrahepatic inoculation of axenic Entamoeba histolytica (strain NIH:200V), all hamsters developed amoebic abscesses in the liver by 7 d after inoculation. All the animals cleared the infection spontaneously by 28 d after inoculation. The establishment of amoebae leading to acute liver abscess was accompanied by significantly reduced levels of antibodies to the plasma membrane (PM) protein of E. histolytica, reduced direct macrophage cytotoxicity, and reduced anti-PM antibody-mediated macrophage-dependent cytotoxicity to amoebic trophozoites. This phase of infection was also accompanied by a significant reduction in cellular sensitization to PM proteins and to phytohaemagglutinin. Reduction in size of the liver abscesses and clearance of infection were accompanied by significant development of anti-PM antibodies, cellular sensitization to the PM proteins, enhanced direct macrophage cytotoxicity, and anti-PM antibody-mediated macrophage-dependent cytotoxicity to trophozoites. The data suggest that the amoebic disease process is modulated by immune responses to the PM protein of E. histolytica.

Elicitation of protective immunity to Entamoeba histolytica--an experimental study

Immunization of hamsters with plasma membrane (PM) antigens of virulent subline of axenic Entamoeba histolytica (NIH: 200 V) entrapped in multilamellar phosphatidyl choline liposomes conferred 100% protection to a subsequent intrahepatic amoebic challenge. In contrast, vaccination of hamsters with live amoebic trophozoites injected intradermally failed to protect any of the animals. The protected animals had significantly high levels of anti-PM anti-amoebic antibodies, cellular sensitization and macrophage-mediated antibody-dependent cytotoxicity against amoebic trophozoites. However, none of the intradermally immunized animals had anti-PM anti-amoebic antibodies at the time of challenge. Such animals also had significantly low macrophage-mediated antibody-dependent cellular cytotoxicity. The data indicate the potential prophylactic use of PM antigens against hepatic amoebic infection.